View All Cancer Clinical Trials | The University of Kansas Cancer Center

Viewed View Trial

TESTPhase II study of Ribociclib or Placebo as Endocrine Therapy for Women with HER2-negative Early Breast CancerTEST

Study Type: Treatment

Phase: II

NCTID: NCT00000001

Principal Investigator: Ericka Abbott

Viewed View Trial

A Randomized Phase III Trial Evaluating the Role of Axillary Lymph Node Dissection in Breast Cancer Patients cT1-3 N1 Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy

Study Type: Treatment

Phase: III

NCTID: NCT01901094

Principal Investigator: Jamie Wagner

Viewed View Trial

A Phase II Randomized Trial of Olaparib NSC-747856 Administered Concurrently with Radiotherapy versus Radiotherapy Alone for Inflammatory Breast Cancer

Study Type: Treatment

Phase: II

NCTID: NCT03598257

Principal Investigator: Priyanka Sharma

Viewed View Trial

A Phase III, Multicenter, Randomized, Open-Label Trial to Evaluate Efficacy and Safety of Ribociclib with Endocrine Therapy as An Adjuvant Treatment in Patients with Hormone Receptor-Positive, HER2-Negative, Early Breast Cancer New Adjuvant TriAl with Ribociclib [LEE011]: NATALEE

Study Type: Treatment

Phase: III

NCTID: NCT03701334

Principal Investigator: Priyanka Sharma

Viewed View Trial

Breast Tissue Biomarkers Predicting Short Term Risk of Breast Cancer

Study Type: Screening

Phase: N/A

NCTID: NCT00291096

Principal Investigator: Carol Fabian

Viewed View Trial

A Multi-national, Multi-center, Open-label, Phase II Clinical Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of DHP107 Liporaxel, Oral Paclitaxel Compared to IV Paclitaxel in Patients with Recurrent or Metastatic Breast Cancer

Study Type: Treatment

Phase: II

NCTID: NCT03326102

Principal Investigator: Priyanka Sharma

Viewed View Trial

Randomized, Double-Blind, Phase III Study of Tucatinib or Placebo in Combination with Ado-Trastuzumab Emtansine T-DM1 For Subjects with Unresectable Locally-Advanced or Metastatic HER2+ Breast Cancer

Study Type: Treatment

Phase: III

NCTID: NCT03975647

Principal Investigator: Qamar Khan

Viewed View Trial

A Randomized PhaseII Trial of Neo-Adjuvant Chemotherapy with Metformin or Placebo for HER2 Positive Operable Breast Cancer The HERMET Trial Old Title: Randomized Trial of Neo-Adjuvant Chemotherapy with or without Metformin for HER2 Positive Operable Breast Cancer, The HERMET Trial

Study Type: Treatment

Phase: II

NCTID: NCT03238495

Principal Investigator: Qamar Khan

Viewed View Trial

Comparing an Operation to Monitoring, with or without Endocrine Therapy Comet For Low Risk DCIS: A Phase III Prospective Randomized Trial

Study Type: Treatment

Phase: III

NCTID: NCT02926911

Principal Investigator: Kelsey Larson

Viewed View Trial

Tailor RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive and T3N0 Breast Cancer

Study Type: Treatment

Phase: III

NCTID: NCT03488693

Principal Investigator: Shane Stecklein

Find a Clinical Trial

TESTPhase II study of Ribociclib or Placebo as Endocrine Therapy for Women with HER2-negative Early Breast CancerTEST

A Randomized Phase III Trial Evaluating the Role of Axillary Lymph Node Dissection in Breast Cancer Patients cT1-3 N1 Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy

A Phase II Randomized Trial of Olaparib NSC-747856 Administered Concurrently with Radiotherapy versus Radiotherapy Alone for Inflammatory Breast Cancer

A Phase III, Multicenter, Randomized, Open-Label Trial to Evaluate Efficacy and Safety of Ribociclib with Endocrine Therapy as An Adjuvant Treatment in Patients with Hormone Receptor-Positive, HER2-Negative, Early Breast Cancer New Adjuvant TriAl with Ribociclib [LEE011]: NATALEE

Breast Tissue Biomarkers Predicting Short Term Risk of Breast Cancer

A Multi-national, Multi-center, Open-label, Phase II Clinical Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of DHP107 Liporaxel, Oral Paclitaxel Compared to IV Paclitaxel in Patients with Recurrent or Metastatic Breast Cancer

Randomized, Double-Blind, Phase III Study of Tucatinib or Placebo in Combination with Ado-Trastuzumab Emtansine T-DM1 For Subjects with Unresectable Locally-Advanced or Metastatic HER2+ Breast Cancer

A Randomized PhaseII Trial of Neo-Adjuvant Chemotherapy with Metformin or Placebo for HER2 Positive Operable Breast Cancer The HERMET Trial Old Title: Randomized Trial of Neo-Adjuvant Chemotherapy with or without Metformin for HER2 Positive Operable Breast Cancer, The HERMET Trial

Comparing an Operation to Monitoring, with or without Endocrine Therapy Comet For Low Risk DCIS: A Phase III Prospective Randomized Trial

Tailor RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive and T3N0 Breast Cancer

Popular Links